Article
Introducing the MUC16 gene: implications for prevention and early detection in epithelial ovarian cancer.
Biological research for nursing - 1 Apr 2005
McLemore Monica R, Aouizerat Bradley
Abstract excerpt
More than 24,000 women in the United States are diagnosed with ovarian cancer every year, and half of these women die from their disease. Stage 1 ovarian cancer is curable in 95% of cases; however, due to inadequate screening tools and lack of symptoms in early disease, ovarian cancer is generally at Stage 3 or 4 when finally diagnosed. CA125 is a tumor antigen used to monitor the progression and regression of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
